The Chosun Ilbo on MSN
Huons merges Huonslab, boosts bio drug R&D
Huons Group is accelerating its focus on pharmaceutical and bio business through restructuring of subsidiaries and mergers ...
16hon MSN
CNN falls for fake GOP lawmaker who claimed Mitch McConnell won ‘staring contest’ from hospital
CNN got duped by a notorious parody account after mistakenly airing a fake Republican congressman’s fabricated account of a ...
On July 5, the Seoul Metropolitan Government announced that the Hongneung Small Giant Research and Development Zone ...
As the South Korean government launches the National Bio-Innovation Committee and accelerates efforts to build a "K-Bio Belt" ...
Hanmi Pharmaceutical announced on July 3 that it will co-host the 'Hanmi × Kiwoom Bio Innovation Day' with Kiwoom Securities ...
Rentschler Biopharma, Syngene, and Symeres announce major leadership changes, appointing new CEOs and executives to drive ...
Global CRO highlights multi-regional trial delivery, early-phase Australia advantages, and expanding support for biotech sponsors across Asia and China ...
SPOILER ALERT: This post spoils the entirety of Season 1 of Netflix’s Little House on the Prairie, particularly the finale ...
Taiwan pavilion to present 40+ technologies from 33 companies at the world's largest biotechnology convention SAN DIEGO, June 22, 2026 /PRNewswire/ -- Taiwan is showcasing the strength of its ...
Next-generation instruments improve rare-cell detection, sterility control, biosafety, and throughput for translational ...
A fresh wave of commitments to pure sciences marks a turning point in the way India's wealthy are giving.
Dave Ricks steered the 150-year-old drug giant to a $1 trillion market cap. Can he defeat pharma’s boom and bust cycle?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results